AMNEAL PHARMACEUTICALS INC (AMRX) Stock Balance Sheet
NASDAQ:AMRX • US03168L1052
Current stock price
11.92 USD
+0.09 (+0.76%)
At close:
11.9 USD
-0.02 (-0.17%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 282.03M | 110.55M | 91.54M | 25.98M | 247.79M | |||
| Receivables | 939.87M | 808.56M | 645.66M | 796.91M | 727.74M | |||
| Inventories | 606.30M | 612.45M | 581.38M | 530.74M | 489.39M | |||
| Other Current Assets | 82.98M | 56.24M | 59.28M | 58.20M | 55.19M | |||
| Total Current Assets | 1.91B | 1.59B | 1.38B | 1.41B | 1.52B | |||
| Non-Current Assets | ||||||||
| PPE Net | 550.33M | 523.69M | 550.14M | 589.36M | 639.00M | |||
| Goodwill | 595.47M | 597.44M | 598.63M | 598.85M | 593.02M | |||
| Intangibles | 563.50M | 732.38M | 890.42M | 1.10B | 1.17B | |||
| Other Non-Current Assets | 57.80M | 60.13M | 55.52M | 103.22M | 20.61M | |||
| Total Non-Current Assets | 1.77B | 1.91B | 2.09B | 2.39B | 2.42B | |||
| TOTAL ASSETS | 3.68B | 3.50B | 3.47B | 3.80B | 3.94B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 100.00M | 179.00M | 60.00M | 0.00 | |||
| Current Portion Of LT Debt. | 10.20M | 227.42M | 36.59M | 33.45M | 33.72M | |||
| Accrued Expenses | 518.02M | 489.59M | 403.12M | 383.05M | 404.06M | |||
| Accounts Payable | 254.67M | 258.69M | 143.57M | 165.98M | 189.08M | |||
| Other Current Liabilities | 98.74M | 54.07M | 84.31M | 110.32M | 50.38M | |||
| Total Current Liabilities | 881.63M | 1.13B | 846.60M | 752.80M | 677.24M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.62B | 2.22B | 2.49B | 2.69B | 2.78B | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 170.64M | 197.53M | 78.65M | 145.16M | 100.20M | |||
| Total Non-Current Liabilities | 2.87B | 2.48B | 2.61B | 2.75B | 2.90B | |||
| TOTAL LIABILITIES | 3.75B | 3.61B | 3.45B | 3.50B | 3.58B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -535.00M | -607.06M | -490.18M | -406.18M | -276.20M | |||
| Additional Paid In Capital | 571.79M | 560.21M | 539.24M | 691.63M | 658.35M | |||
| Minority Interest | 76.76M | 64.73M | 41.52M | -89.49M | 23.54M | |||
| Common Shares | 3.15M | 3.10M | 3.07M | 3.04M | 3.01M | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -110.73M | -65.51M | -32.35M | 9.94M | -24.83M | |||
| Shares Outstanding | 314.56M | 309.88M | 458.68M | 303.61M | 301.53M | |||
| Tangible Book Value per Share | -3.91 | -4.64 | -3.20 | -4.60 | -4.64 | |||
| Total Shareholders' Equity | -70.79M | -109.27M | 19.78M | 298.42M | 360.34M | |||
| TOTAL LIABILITIES AND EQUITY | 3.68B | 3.50B | 3.47B | 3.80B | 3.94B | |||
| Statistics | ||||||||
| Debt/Equity | -37.01 | -21.22 | 134.73 | 9.22 | 7.71 | |||
| Current Ratio | 2.17 | 1.41 | 1.63 | 1.88 | 2.24 | |||
| Return On Assets (ROA) | 1.96% | -3.34% | -2.42% | -3.42% | 0.27% | |||
| Return On Equity (ROE) | N/A | N/A | -424.61% | -43.56% | 2.95% | |||
| Return On Invested Capital (ROIC) | 11.24% | 11.13% | 7.74% | 5.07% | 5.24% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 12.50% | 11.66% | 8.00% | 5.11% | 5.67% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 23.19% | 26.69% | 17.73% | 11.36% | 13.63% | |||
All data in USD , ROIC based on taxRate of 0.21